Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Primary endpoint not met with ipatasertib added to paclitaxel in HR+, HER2- breast cancer

Sep. 29, 2020

Phase I results reported for fusion protein tTF-NGR in advanced cancer patients

Sep. 29, 2020

New sphingosine 1-phosphate receptor 1 ligands discovered at the University of Buea

Sep. 29, 2020

Statins help pancreatic tumors go from bad to worse

Sep. 29, 2020

Lenvatinib effective in combo with pembrolizumab in PD-L1-refractory melanoma

Sep. 28, 2020

Ayvakyt approved in E.U. for unresectable or metastatic PDGFRA D842V mutant GIST

Sep. 28, 2020

Basilea initiates phase I/II study of derazantinib in advanced gastric cancer

Sep. 28, 2020

New phosphatidylserine synthase inhibitors disclosed by Daiichi Sankyo

Sep. 28, 2020

Sichuan Kelun-Biotech Biopharmaceutical discovers PRMT5 inhibitors

Sep. 28, 2020

Voronoi synthesizes new dual specificity protein kinase TTK inhibitors

Sep. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...